Will U.S. Steel's Earnings Move The Stock?
CHONGQING, CHINA - APRIL 20, 2025 - Steel piled up at Guoyuan Port in Chongqing, China on April 20, ... More 2025 (Photo credit should read CFOTO/Future Publishing via Getty Images)
United States Steel (NYSE:X) is scheduled to announce its earnings on May 1, 2025. The company has a current market capitalization of $9.6 billion. Over the past twelve months, revenue totaled $16 billion, and it was operationally profitable with $155 million in operating profits and net income of $384 million. However, if you are looking for growth with lower volatility than individual stocks, the Trefis High Quality portfolio offers an alternative – having surpassed the S&P 500 and delivered returns exceeding 91% since its inception.
View earnings reaction history of all stocks
Some insights on one-day (1D) post-earnings returns:
Supplementary data for 5-Day (5D) and 21-Day (21D) returns post earnings are summarized, along with the statistics in the table below.
X 1D, 5D, and 21D Post Earnings Return
A relatively lower-risk strategy (though not effective if the correlation is weak) is to analyze the correlation between short-term and medium-term returns following earnings, identify a pair that demonstrates the highest correlation, and carry out the suitable trade. For instance, if the correlation between 1D and 5D displays the highest correlation, a trader can position themselves "long" for the subsequent 5 days if the 1D post-earnings return is positive. Here are some correlation statistics derived from 5-year and 3-year (more recent) histories. Note that the correlation 1D_5D refers to the relationship between 1D post-earnings returns and the ensuing 5D returns.
X Correlation Between 1D, 5D, and 21D Historical Returns
Occasionally, the performance of peers can affect post-earnings stock reactions. In fact, the pricing-in might commence prior to the earnings announcements. Here is some historical information on the past post-earnings performance of United States Steel stock in comparison with the stock performance of peers that announced earnings just ahead of United States Steel. For an equitable comparison, peer stock returns also portray post-earnings one-day (1D) returns.
X Correlation With Peer Earnings
Discover more about Trefis RV strategy that has outperformed its all-cap stocks benchmark (encompassing all 3, the S&P 500, S&P mid-cap, and Russell 2000), generating robust returns for investors. Additionally, if you seek growth with a steadier experience than an individual stock like United States Steel, consider the High Quality portfolio, which has outstripped the S&P and recorded >91% returns since inception.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
30 minutes ago
- Forbes
Samsung Signals Major New Galaxy Z Fold 7 Phone Upgrade
The Samsung Galaxy Z Fold 7 will likely have an improved camera. (Photo by Future Publishing via ... More Getty Images) After debuting the Galaxy S25 Edge last month, which came with a bunch of freebies and launched a new device range, Samsung has teased its next phone release: the Galaxy Z Fold 7. It is no secret that the Korean company will release the seventh generation of the Galaxy Fold and Flip lines this summer. The big question, however, is will the new Fold be an iteration on previous models, or a major redesign that includes a larger cover screen? A design change that Samsung fans have requested for years. The good news is that those prayers appear to have been answered. I am reliably told that the Galaxy Z Fold 7 does have a significantly larger cover screen, something closer to the size of a standard smartphone. Samsung has also published a teaser press release that not-so-subtly hints at a bigger display on the new foldable. 'For years, Samsung has listened to users asking for bigger screens, better cameras and new ways to connect and create. The demand is clear — an Ultra-experience that goes beyond a simple list of upgraded features in a smaller and more portable form factor.' The press release reads. The Fold 7 isn't directly named, but the blacked out teaser image clearly shows a Galaxy Fold silhouette. Digital Trends also received a press image with the file name 'Galaxy-Z-Fold7-Z-Flip7-Pre-tease-Bartype_1920x1080.gif.' As I say, the existence of the Fold 7 isn't a surprise, but the early teaser and the heavy hint of a bigger display is. It's worth saying that the press images I received had no revealing file names. Samsung's not-so mysterious foldable phone The repeated use of the word 'Ultra' in the press releases also hints at a long rumored higher-end version of the Fold 7. Although the file name discovered by Digital Trends doesn't suggest that the Korean company will launch two separate Fold 7 units (an Ultra and a standard model), rather the Fold will have the word 'Ultra' tacked on to its name. Maybe Samsung has a secret second Fold device up its sleeve, but I doubt it. What is more likely is that Samsung is renaming the Fold to give it a marketing boost and reflect the device's new hardware credentials. Samsung implies that the new handset will have 'better cameras,' which has been a consistent problem for the Fold (and Flip) range. The Fold 6 is a $1,899 smartphone, $600 more than the Galaxy S25 Ultra, the former sports worse camera performance despite being significantly more expensive. The new camera setup alongside a bigger screen answers two of the most prominent quibbles Samsung users have voiced about its foldable phones. The final mystery is the new device's battery life. We will have to see how new, more resource-intensive specifications, impact battery life on a foldable phone that was already power-hungry.
Yahoo
33 minutes ago
- Yahoo
Public markets primed for US IPO revival despite tariff uncertainty, NYSE President Martin says
By Arasu Kannagi Basil (Reuters) -Intercontinental Exchange-owned NYSE's President Lynn Martin said on Thursday that public markets were ready for well-prepared companies despite tariff unease as easing volatility was setting the stage for a rebound in U.S. IPO activity. Optimism that 2025 would finally be the year for a strong rebound in U.S. IPO market activity has recently been tempered by tariff-driven uncertainty, but the window seems to be opening up again after volatility eased and equities bounced back. "There's been this narrative in the market, particularly for the last two years. It's a bit false that companies can't go public," Martin said at the Piper Sandler Global Exchange & Trading Conference. The companies debuting at this time were public-market ready, she said, highlighting the successful listings of cybersecurity firm Rubrik and social media platform Reddit last year. "They were ready to go. They went, and they've done extraordinarily well," Martin said. Analysts say the IPO market could be in the early stages of a broader pickup, but that sustained stability was needed before the window opens fully. "We expect approximately one or two deals per week in June, ramping up a bit in July after Independence Day, and if all goes well, a full rebound in September, October after the summer lull," said Matt Kennedy, senior strategist at Renaissance Capital, a provider of IPO-focused research and ETFs. NYSE TEXAS The impending launch of the Texas Stock Exchange, backed by Wall Street giants BlackRock and Citadel Securities, is set to heat up the competition in listings markets. The NYSE was following its playbook, talking to its customers about why more of them were moving to Texas, Martin said. NYSE Texas officially opened for business in March and has secured a handful of companies over the past few weeks - including Trump Media & Technology Group - as its "founding" members. "The conversations we're having are incredibly positive," Martin said, adding that NYSE Texas had another double-digit dual listing lined up. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Is this S&P 500 stock a once-in-a-decade passive income opportunity?
The S&P 500 has recovered from its volatile start to the year and is within touching distance of its record highs. At the same time, some quality shares are trading at exceptionally low prices. One example is Johnson & Johnson (NYSE:JNJ). As a rule, I stay away from pharmaceutical stocks, but I'm considering making a rare exception for this one. Johnson & Johnson has recently divested its consumer products business. The company now generates around 66% of its revenues from pharmaceuticals and 33% from medical devices. The main reason I generally stay away from stocks like this is I don't feel like I can evaluate them accurately. I'm not a medical professional and that means I can't confidently evaluate drug pipelines. That makes it hard to work out which businesses have the best prospects. And in fairness to me, it's not always straightforward even for people who do have specialist expertise in this sector. Johnson & Johnson does have some competitive strengths in this area – most notably its scale and its exceptional balance sheet. But there's something else that stands out to me about the company. A key part of what makes Johnson & Johnson unique is its culture. And this is set out in the 'Credo' – a document, which states that the company's priorities are, in order: Doctors, patients, nurses, and users of its products Employees Communities Shareholders In other words, focus on putting customers first and doing the right thing and the returns will follow. This ethical outlook is a key part of what has allowed the business to survive and thrive over decades. A lot of businesses have codes of conduct or ethical frameworks. But there's evidence that Johnson & Johnson's Credo means its culture is more entrenched than it is at other companies. The firm's reaction to the 1982 Tylenol crisis is now a well-known case study in ethical leadership. And it doesn't take specialist medical knowledge to appreciate the significance of this. Right now, shares in Johnson & Johnson come with a dividend yield of around 3.25%. That doesn't exactly jump out as a passive income opportunity, but it's the highest it has been in the last 10 years. This is a sign investors are unusually pessimistic about a stock they normally hold in high regard. And a key reason for this is the situation in the US at the moment. The situation is still developing, but potential risks include slower drug approval processes and price controls. Neither of these would be good for companies like Johnson & Johnson. The risk is real, but this might be the kind of opportunity that comes around once in a decade. Given the company's long-term strengths, I think it's worth taking seriously. I think Johnson & Johnson's biggest unique strength is its culture. Even if I'm wrong, there's clearly a lot to like about a company that has more than 50 years of consecutive dividend increases. Most of the time, the stock market appreciates the quality of the business. But it's unusually cheap at the moment and on that basis, it's certainly one to consider right now. The post Is this S&P 500 stock a once-in-a-decade passive income opportunity? appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Stephen Wright has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
